Sign in
4

Changes in Ownership

NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-23-006256

Chief Financial Officer sold 1,283 shares at $109.98 ($141,108)

From the SEC's structured data for this filing

Trades in this filing

ABERNETHY MATT · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-01-31 Sale : show line 1 in the form −1,283 $109.98 $141,108 21,357 D
Open-market sales · 1,283 sh · avg $109.98 · $141,108
Loading xslF345X03/doc4.xml…